Summit Therapeutics PLC
Statements
Cash Flow
Summit Therapeutics PLC (SMMT) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at -168 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q1 18 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q1 19 | Q2 19 | Q3 19 | Q1 20 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -5.8 | -10 | 9.5 | -10 | -9.6 | -9.7 | -14 | -3.9 | -4.1 | 1.8 | 1.8 | -10 | -8.6 | -5.0 | -15 | -15 | -13 | -5.9 | -15 | -14 | -17 | -6.8 | -14 | -16 | -7.7 | 4.2 | -11 | -23 | -12 | -15 | -24 | -26 | -23 | -39 | -47 | -69 | -93 | -76 | -93 | -168 | -429 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.5 | 0.4 | 0.5 | 0.4 | 0.4 | 0.5 | 0.5 | 0.4 | 0.5 | 0.5 | 0.4 | 0.3 | 0.4 | 0.5 | 0.4 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.6 | 0.5 | 0.1 | 0.0 | 0.0 | 0.5 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -7.1 | -7.0 | |
| 0.5 | 0.4 | 0.7 | 0.7 | 0.8 | 0.8 | 0.8 | 3.9 | 0.8 | 0.2 | 0.2 | 0.2 | 0.3 | 0.3 | 0.5 | 0.4 | 0.3 | 0.4 | 0.6 | 2.7 | 2.0 | 4.2 | 3.0 | 2.1 | 2.5 | 2.2 | 2.2 | 1.5 | 0.6 | 6.9 | 7.6 | 8.8 | 15 | 8.8 | 8.6 | 97 | 131 | 83 | 55 | 86 | 355 | |
| 1.6 | -0.2 | -0.1 | -4.9 | 0.3 | -1.0 | 2.1 | 3.3 | 0.1 | – | 4.1 | -2.5 | 1.4 | -3.5 | 2.4 | 2.9 | – | -0.7 | 2.8 | 3.7 | 6.6 | 5.2 | 4.6 | 4.6 | 12 | -1.4 | -1.4 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| -0.3 | -3.9 | 17 | -6.1 | -1.0 | -1.0 | -52 | 2.8 | -1.2 | 1.3 | 1.3 | -1.3 | -1.2 | 0.3 | -5.2 | -3.1 | -0.3 | 3.3 | -2.1 | 0.3 | -6.1 | 7.9 | -2.6 | -6.3 | 6.8 | 9.9 | -0.1 | -10 | 3.4 | 6.6 | 3.3 | 2.4 | 6.8 | -0.5 | -4.8 | 5.8 | 7.9 | 6.2 | -1.3 | 4.2 | 17 | |
| 0.1 | 0.4 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | 0.3 | 0.0 | 0.2 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.1 | 0.3 | 0.2 | 0.0 | 1.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.3 | 0.1 | 0.1 | 0.1 | 0.2 | 1.0 | 1.3 | |
| 0.0 | -0.4 | -0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -0.3 | 0.0 | 0.0 | -0.3 | 0.0 | -0.2 | -0.1 | -0.1 | 0.0 | 0.0 | 0.0 | -0.1 | 0.0 | -0.1 | -0.3 | -0.2 | 0.0 | 0.0 | -522 | 0.2 | -2.9 | 48 | 16 | -158 | -83 | 67 | 124 | -0.1 | – | -360 | -0.2 | 223 | – | |
| – | – | – | – | – | 0.0 | 0.0 | 0.0 | 0.0 | – | 0.0 | 0.0 | 0.0 | 0.0 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| 0.4 | 0.0 | 0.0 | 15 | 15 | 222,479 | 0.0 | 0.0 | 0.0 | – | 0.0 | -20 | 0.0 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| 0.0 | – | – | – | – | 0.0 | -0.1 | -0.1 | 0.0 | – | -0.1 | -0.1 | -0.1 | 0.0 | 0.1 | 55 | – | 55 | -55 | 25 | 25 | 25 | -25 | -25 | 520 | – | – | – | – | – | – | – | -76 | -25 | – | – | – | 0.0 | – | – | – | |
| 0.0 | 0.0 | 0.0 | 14 | 19 | 20 | -0.8 | -0.4 | 19 | -0.1 | -0.1 | -0.1 | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | 37 | 40 | 15 | 0.5 | 0.9 | 19 | -0.8 | 68 | 424 | 65 | -0.1 | 0.2 | 4.9 | 0.4 | 158 | 156 | -19 | 5.9 | 25 | 34 | 426 | 2.9 | 457 | 919 | |
| -6.6 | -11 | 8.9 | 3.5 | 10 | 10 | -16 | -5.9 | 14 | 1.9 | 1.9 | -11 | -7.8 | -8.9 | -19 | -15 | -12 | 33 | 26 | 0.9 | -17 | -6.3 | 4.3 | -17 | 58 | 429 | -467 | -23 | -15 | 38 | -7.8 | -26 | 50 | 8.9 | 83 | -44 | -59 | -9.9 | -90 | 512 | 352 | |
| -6.8 | -11 | 12 | -14 | -9.6 | -9.7 | -14 | -4.7 | -6.8 | 1.8 | 1.8 | -10 | -8.6 | -5.2 | -15 | -15 | -13 | -5.9 | -15 | -14 | -17 | -6.9 | -15 | -16 | -7.7 | 4.2 | -11 | -23 | -12 | -15 | -24 | -26 | -23 | -39 | -48 | -69 | -93 | -76 | -93 | -169 | -431 |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.